|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 |
| (11) | Patento numeris | 2668287 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12700864.7 |
| Europos patento paraiškos padavimo data | 2012-01-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-12-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-09-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2012/051164 |
| Data | 2012-01-25 |
| (87) | Numeris | WO 2012/101183 |
| Data | 2012-08-02 |
| (30) | Numeris | Data | Šalis |
| 201161457191 P | 2011-01-25 | US | |
| 201161457743 P | 2011-05-25 | US | |
| 201261588390 P | 2012-01-19 | US |
| (72) |
CERVINO, Alessandra, FR
POPA-NITA, Oana, FR
PLASSAIS, Jonathan, FR
|
| (73) |
TC LAND Expression,
21, rue de la Noue Bras de Fer Bio Ouest Ile de Nantes, 44200 Nantes,
FR
|
| (54) | GENES AND GENES COMBINATIONS BASED ON GENE MKNK1 PREDICTIVE OF EARLY RESPONSE OR NON RESPONSE OF SUBJECTS SUFFERING FROM RHEUMATOID ARTHRITIS TO TNF-ALPHA BLOCKING MONOCLONAL ANTIBODY |
| GENES AND GENES COMBINATIONS BASED ON GENE MKNK1 PREDICTIVE OF EARLY RESPONSE OR NON RESPONSE OF SUBJECTS SUFFERING FROM RHEUMATOID ARTHRITIS TO TNF-ALPHA BLOCKING MONOCLONAL ANTIBODY |